+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Silico Clinical Trials Market - Global Forecast 2025-2030- Product Image
In Silico Clinical Trials Market - Global Forecast 2025-2030- Product Image
Sale

In Silico Clinical Trials Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716008
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In silico clinical trials are transforming how pharmaceutical and medical technology companies optimize research and development, offering virtual modeling and simulation as a robust approach to accelerate safe, effective therapeutic innovations.

Market Snapshot: In Silico Clinical Trials Market Growth and Outlook

The In Silico Clinical Trials Market grew from USD 3.50 billion in 2024 to USD 3.81 billion in 2025. With a projected CAGR of 9.27%, it is expected to reach USD 5.97 billion by 2030. This sustained expansion reflects increasing adoption by pharmaceutical, biotech, and medical device stakeholders seeking efficiency, risk reduction, and accelerated market entry for innovative therapies and products.

Scope & Segmentation

  • Product Types: Consulting and training, custom simulation services, model development and validation, simulation software, trial design software, virtual patient modeling.
  • Development Phases: Models and services addressing every trial stage from Phase I to IV.
  • Technology Platforms: Artificial intelligence, machine learning, cloud-based simulations, digital twin modeling, mechanistic modeling, virtual patient populations.
  • Applications: Disease modeling, drug development, medical device testing.
  • Therapeutic Areas: Simulation platforms for cardiovascular, infectious diseases, neurology, oncology, and rare disease scenarios.
  • End Users: Academic research institutes, contract research organizations, medical device companies, pharmaceutical and biotech companies, regulatory agencies.
  • Geographies: Americas (including United States, Canada, Brazil, and more), Europe, Middle East & Africa (such as United Kingdom, Germany, South Africa), and Asia-Pacific (including China, India, Japan, Australia).
  • Key Market Participants: Abzena Ltd., Aitia NV, Certara, Dassault Systèmes, ICON plc, IBM Corporation, InSilicoTrials Technologies, IQVIA Holdings, Recursion Pharmaceuticals, Schrödinger, Simulations Plus, WuXi AppTec, ZMT Zurich MedTech, among others.

Key Takeaways for Senior Decision-Makers

  • In silico clinical trials offer a scalable framework to evaluate and de-risk therapies, especially beneficial for rare diseases and complex drug-device interactions where traditional recruitment is challenging.
  • Organizations integrating AI, mechanistic modeling, and real-world data benefit from agile protocol development, rapid iteration, and optimized resource allocation throughout the product pipeline.
  • Companies are forming partnerships with technology vendors and research institutions to build flexible digital trial infrastructures and share compliance expertise, driving operational resilience.
  • Collaboration between industry and regulatory bodies is advancing best practices for digital evidence generation, building confidence in simulation-derived outcomes and clarifying submission expectations.
  • Regional dynamics are shaping adoption, with North America emphasizing innovation leadership, Europe focusing on regulatory harmonization, and Asia-Pacific investing in local AI and simulation capacity.

Tariff Impact: Navigating Cost and Operational Shifts

New United States tariffs on imported simulation hardware, software, and research services have increased operational costs for stakeholders across the sector. Market participants are actively adjusting procurement, licensing, and international collaboration strategies to mitigate these cross-border expenses, reassessing locations for research activities and prioritizing flexible technology architectures for deployment in diverse jurisdictions.

Methodology & Data Sources

This report applies a rigorous research framework combining analysis of published literature, regulatory guidelines, industry reports, and extensive primary research with senior executives, technical leads, and regulatory authorities. Quantitative and qualitative findings are validated through subject matter expert reviews and iterative model assessments.

Why This Report Matters

  • Enables C-level leaders to benchmark digital R&D investments against emerging best practices in in silico clinical trials.
  • Guides strategic planning by detailing segmentation, technology use cases, and regional market dynamics essential for market entry or expansion.
  • Supports evidence-based decision-making by presenting actionable conclusions grounded in robust, multi-source primary and secondary market intelligence.

Conclusion

In silico clinical trials are accelerating the transformation of global drug and device development. By leveraging advanced simulations, industry leaders can reduce uncertainty, enhance ethical standards, and streamline innovation pathways in a rapidly evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of hybrid in silico and real-world evidence platforms to accelerate oncology drug approval processes
5.2. Implementation of regulatory framework alignment for computational trial evidence submission in major global markets
5.3. Integration of mechanistic digital twin simulations for pediatric rare disease drug development
5.4. Adoption of advanced AI-driven pharmacokinetic and pharmacodynamic modeling for personalized virtual patient cohorts
5.5. Leveraging cloud-based high-performance computing to scale virtual clinical trials across geographically diverse populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In Silico Clinical Trials Market, by Product Type
8.1. Introduction
8.2. Services
8.2.1. Consulting & Training
8.2.2. Custom Simulation Services
8.2.3. Model development & validation
8.3. Software Solutions
8.3.1. Simulation Software
8.3.2. Trial Design Software
8.3.3. Virtual Patient Modeling
9. In Silico Clinical Trials Market, by Phase
9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Phase IV
10. In Silico Clinical Trials Market, by Technology Platform
10.1. Introduction
10.2. Artificial Intelligence & Machine Learning
10.3. Cloud-Based Simulations
10.4. Digital Twin
10.5. Mechanistic Modeling
10.6. Virtual Patient Population
11. In Silico Clinical Trials Market, by Application
11.1. Introduction
11.2. Disease Modeling
11.3. Drug Development
11.4. Medical Device Testing
12. In Silico Clinical Trials Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular
12.2.1. Arrhythmia Simulation
12.2.2. Atherosclerosis Simulation
12.2.3. Heart Failure Modeling
12.3. Infectious Diseases
12.3.1. Parasitic Disease Prediction
12.3.2. Viral Infection Simulation
12.4. Neurology
12.4.1. Alzheimer's Simulation
12.4.2. Epilepsy Simulation
12.4.3. Parkinson's Disease Modeling
12.5. Oncology
12.5.1. Hematologic Malignancies
12.5.2. Solid Tumors
12.6. Rare Diseases
12.6.1. Genetic Disorder Simulation
12.6.2. Orphan Drug Modeling
13. In Silico Clinical Trials Market, by End User
13.1. Introduction
13.2. Academic & Research Institutes
13.3. Contract Research Organizations
13.4. Medical Device Companies
13.5. Pharmaceutical & Biotech Companies
13.6. Regulatory Agencies
14. Americas In Silico Clinical Trials Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa In Silico Clinical Trials Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific In Silico Clinical Trials Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abzena Ltd.
17.3.2. Aitia NV
17.3.3. Certara, Inc.
17.3.4. Dassault Systèmes SE
17.3.5. Evotec SE
17.3.6. Exscientia Limited
17.3.7. GNS Healthcare Inc.
17.3.8. IBM Corporation
17.3.9. ICON plc
17.3.10. Immunetrics Inc.
17.3.11. Insilico Medicine, Inc.
17.3.12. InSilicoTrials Technologies SpA
17.3.13. IQVIA Holdings Inc.
17.3.14. Novadiscovery SA
17.3.15. PAREXEL INTERNATIONAL, INC.
17.3.16. Recursion Pharmaceuticals, Inc.
17.3.17. Schrödinger, Inc.
17.3.18. Simulations Plus, Inc.
17.3.19. The AnyLogic Company
17.3.20. Virtonomy GmbH
17.3.21. WuXi AppTec Co., Ltd.
17.3.22. ZMT Zurich MedTech AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IN SILICO CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. IN SILICO CLINICAL TRIALS MARKET: RESEARCHAI
FIGURE 28. IN SILICO CLINICAL TRIALS MARKET: RESEARCHSTATISTICS
FIGURE 29. IN SILICO CLINICAL TRIALS MARKET: RESEARCHCONTACTS
FIGURE 30. IN SILICO CLINICAL TRIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN SILICO CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CONSULTING & TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CUSTOM SIMULATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CUSTOM SIMULATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MODEL DEVELOPMENT & VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MODEL DEVELOPMENT & VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SIMULATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SIMULATION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRTUAL PATIENT MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRTUAL PATIENT MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE & MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE & MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CLOUD-BASED SIMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CLOUD-BASED SIMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DIGITAL TWIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DIGITAL TWIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MECHANISTIC MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MECHANISTIC MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRTUAL PATIENT POPULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRTUAL PATIENT POPULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ARRHYTHMIA SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ARRHYTHMIA SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ATHEROSCLEROSIS SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ATHEROSCLEROSIS SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY HEART FAILURE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY HEART FAILURE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PARASITIC DISEASE PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PARASITIC DISEASE PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRAL INFECTION SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY VIRAL INFECTION SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ALZHEIMER'S SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ALZHEIMER'S SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY EPILEPSY SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY EPILEPSY SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PARKINSON'S DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PARKINSON'S DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY GENETIC DISORDER SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ORPHAN DRUG MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ORPHAN DRUG MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 175. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 178. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 179. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 180. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 181. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 182. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 183. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 184. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 185. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 190. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 191. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 192. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 193. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 194. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 195. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 198. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 199. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 210. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 211. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 214. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 215. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 216. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 217. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 218. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 219. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 220. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 221. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this In Silico Clinical Trials market report include:
  • Abzena Ltd.
  • Aitia NV
  • Certara, Inc.
  • Dassault Systèmes SE
  • Evotec SE
  • Exscientia Limited
  • GNS Healthcare Inc.
  • IBM Corporation
  • ICON plc
  • Immunetrics Inc.
  • Insilico Medicine, Inc.
  • InSilicoTrials Technologies SpA
  • IQVIA Holdings Inc.
  • Novadiscovery SA
  • PAREXEL INTERNATIONAL, INC.
  • Recursion Pharmaceuticals, Inc.
  • Schrödinger, Inc.
  • Simulations Plus, Inc.
  • The AnyLogic Company
  • Virtonomy GmbH
  • WuXi AppTec Co., Ltd.
  • ZMT Zurich MedTech AG

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.97 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Industry (Medical Devices, Pharmaceutical), By Therapeutic Area (Oncology, Infectious Disease, Hematology), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Industry (Medical Devices, Pharmaceutical), By Therapeutic Area (Oncology, Infectious Disease, Hematology), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
In Silico Clinical Trials - Global Strategic Business Report - Product Image

In Silico Clinical Trials - Global Strategic Business Report

  • Report
  • 396 Pages
  • Global
From
Global In Silico Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global In Silico Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 119 Pages
  • Global
From
In Silico Clinical Trials Market Report 2025 - Product Image

In Silico Clinical Trials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
In Silico Clinical Trials Market Report and Forecast 2025-2034 - Product Image

In Silico Clinical Trials Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the In Silico Clinical Trials Market

In Silico Clinical Trials are a type of clinical trial that uses computer simulations and models to evaluate the safety and efficacy of a drug or medical device. This type of trial is conducted virtually, without the need for physical testing on humans or animals. It is used to assess the safety and efficacy of a drug or device before it is tested on humans. In Silico Clinical Trials can be used to reduce the cost and time associated with traditional clinical trials, as well as to reduce the risk of adverse events. In Silico Clinical Trials are becoming increasingly popular in the clinical trial industry, as they offer a cost-effective and efficient way to evaluate the safety and efficacy of a drug or device. They are also used to identify potential drug-drug interactions and to assess the potential for drug-drug interactions. Companies in the In Silico Clinical Trials market include Simulations Plus, Certara, Entelos, and In Silico Biosciences. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.